tradingkey.logo


Globus Medical Inc

GMED

58.240USD

-0.500-0.85%
āļ›āļīāļ” 09/15, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
7.87BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
22.05P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Globus Medical Inc āļšāļĢāļīāļĐāļąāļ—
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™GMED
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Globus Medical Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 08, 2012
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Keith W. Pfeil
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™5300
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Mar 08
āļ—āļĩāđˆāļ­āļĒāļđāđˆ2560 General Armistead Ave
āđ€āļĄāļ·āļ­āļ‡AUDUBON
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNYSE Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ19403
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ16109301800
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.globusmedical.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™GMED
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 08, 2012
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Keith W. Pfeil
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Dr. John A. Deford, Ph.D.
Dr. John A. Deford, Ph.D.
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
483.86M
80.90%
International
114.26M
19.10%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 16 āļŠ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 16 āļŠ.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
āļ­āļ·āđˆāļ™ āđ†
68.34%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
āļ­āļ·āđˆāļ™ āđ†
68.34%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
51.77%
Investment Advisor/Hedge Fund
35.76%
Hedge Fund
10.02%
Pension Fund
1.99%
Research Firm
1.43%
Sovereign Wealth Fund
1.07%
Bank and Trust
1.07%
Individual Investor
0.69%
Private Equity
0.29%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
2023Q1
857
78.38M
100.58%
-6.61M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
10.88M
9.64%
+45.25K
+0.42%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.87M
8.73%
+23.63K
+0.24%
Mar 31, 2025
Janus Henderson Investors
7.01M
6.2%
+391.41K
+5.92%
Mar 31, 2025
Burgundy Asset Management Ltd.
2.80M
2.48%
+183.64K
+7.01%
Mar 31, 2025
State Street Global Advisors (US)
3.62M
3.2%
+21.05K
+0.59%
Mar 31, 2025
JP Morgan Asset Management
2.45M
2.17%
-176.33K
-6.72%
Mar 31, 2025
Sculptor Capital Management, Inc
2.09M
1.85%
+15.00K
+0.72%
Mar 31, 2025
William Blair Investment Management, LLC
2.27M
2.01%
+1.04M
+84.46%
Mar 31, 2025
Hawk Ridge Capital Management LP
1.68M
1.49%
+4.56K
+0.27%
Mar 31, 2025
Geneva Capital Management LLC
1.83M
1.62%
+17.81K
+0.98%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ.āļĒ.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
First Trust Indxx Medical Devices ETF
1.62%
ProShares MSCI Transformational Changes ETF
0.2%
Strive 1000 Growth ETF
0.01%
AvantisUS Mid Cap Value ETF
0.01%
Vanguard US Momentum Factor ETF
0%
Vanguard S&P Mid-Cap 400 Value Index Fund
0%
Inspire Small/Mid Cap ESG ETF
0%
John Hancock Multifactor Small Cap ETF
0%
First Trust Mid Cap Core Alphadex Fund
0%
First Trust Mid Cap Value AlphaDEX Fund
0%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
First Trust Indxx Medical Devices ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.62%
ProShares MSCI Transformational Changes ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.2%
Strive 1000 Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.01%
AvantisUS Mid Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.01%
Vanguard US Momentum Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
Vanguard S&P Mid-Cap 400 Value Index Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
Inspire Small/Mid Cap ESG ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
John Hancock Multifactor Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
First Trust Mid Cap Core Alphadex Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
First Trust Mid Cap Value AlphaDEX Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0%
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™